 
                        | Product NDC: | 49886-001 | 
| Proprietary Name: | Migralex | 
| Non Proprietary Name: | Aspirin buffered with magnesium oxide | 
| Active Ingredient(s): | 500; 75 mg/1; mg/1 & nbsp; Aspirin buffered with magnesium oxide | 
| Administration Route(s): | ORAL | 
| Dosage Form(s): | TABLET, COATED | 
| Coding System: | National Drug Codes(NDC) | 
| Product NDC: | 49886-001 | 
| Labeler Name: | Migralex Inc. | 
| Product Type: | HUMAN OTC DRUG | 
| FDA Application Number: | part343 | 
| Marketing Category: | OTC MONOGRAPH NOT FINAL | 
| Start Marketing Date: | 20091115 | 
| Package NDC: | 49886-001-01 | 
| Package Description: | 20 TABLET, COATED in 1 BOTTLE, PLASTIC (49886-001-01) | 
| NDC Code | 49886-001-01 | 
| Proprietary Name | Migralex | 
| Package Description | 20 TABLET, COATED in 1 BOTTLE, PLASTIC (49886-001-01) | 
| Product NDC | 49886-001 | 
| Product Type Name | HUMAN OTC DRUG | 
| Non Proprietary Name | Aspirin buffered with magnesium oxide | 
| Dosage Form Name | TABLET, COATED | 
| Route Name | ORAL | 
| Start Marketing Date | 20091115 | 
| Marketing Category Name | OTC MONOGRAPH NOT FINAL | 
| Labeler Name | Migralex Inc. | 
| Substance Name | ASPIRIN; MAGNESIUM OXIDE | 
| Strength Number | 500; 75 | 
| Strength Unit | mg/1; mg/1 | 
| Pharmaceutical Classes |